Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Avadel Pharmaceuticals Plc ADR (AVDL)

Avadel Pharmaceuticals Plc ADR (AVDL)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.77 +0.17 (+1.98%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.77 unch (unch) 16:01 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
8.41
Day High
8.80
Open 8.50
Previous Close 8.60 8.60
Volume 826,700 826,700
Avg Vol 1,104,935 1,104,935
Stochastic %K 95.31% 95.31%
Weighted Alpha -32.23 -32.23
5-Day Change +0.74 (+9.22%) +0.74 (+9.22%)
52-Week Range 6.38 - 19.09 6.38 - 19.09
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 657,077
  • Shares Outstanding, K 96,629
  • Annual Sales, $ 169,120 K
  • Annual Income, $ -48,830 K
  • EBIT $ -42 M
  • EBITDA $ -40 M
  • 60-Month Beta 1.52
  • Price/Sales 5.01
  • Price/Cash Flow N/A
  • Price/Book 11.24

Options Overview Details

View History
  • Implied Volatility 74.90% ( -4.05%)
  • Historical Volatility 53.27%
  • IV Percentile 64%
  • IV Rank 50.41%
  • IV High 118.75% on 10/16/24
  • IV Low 30.31% on 06/12/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 681
  • Volume Avg (30-Day) 408
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 30,942
  • Open Int (30-Day) 31,521

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.07
  • Number of Estimates 7
  • High Estimate -0.02
  • Low Estimate -0.14
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +76.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.38 +37.46%
on 04/09/25
Period Open: 8.20
8.80 -0.34%
on 04/25/25
+0.57 (+6.95%)
since 03/25/25
3-Month
6.38 +37.46%
on 04/09/25
Period Open: 7.85
9.34 -6.10%
on 02/12/25
+0.92 (+11.72%)
since 01/24/25
52-Week
6.38 +37.46%
on 04/09/25
Period Open: 17.82
19.09 -54.06%
on 05/03/24
-9.05 (-50.79%)
since 04/25/24

Most Recent Stories

More News
Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience

AVDL : 8.77 (+1.98%)
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

AVDL : 8.77 (+1.98%)
Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

AVDL : 8.77 (+1.98%)
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference

AVDL : 8.77 (+1.98%)
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians

AVDL : 8.77 (+1.98%)
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

AVDL : 8.77 (+1.98%)
Avadel: Q4 Earnings Snapshot

Avadel: Q4 Earnings Snapshot

AVDL : 8.77 (+1.98%)
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

AVDL : 8.77 (+1.98%)
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3

AVDL : 8.77 (+1.98%)
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales

AVDL : 8.77 (+1.98%)

Business Summary

Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates...

See More

Key Turning Points

3rd Resistance Point 9.30
2nd Resistance Point 9.05
1st Resistance Point 8.91
Last Price 8.77
1st Support Level 8.52
2nd Support Level 8.27
3rd Support Level 8.13

See More

52-Week High 19.09
Fibonacci 61.8% 14.23
Fibonacci 50% 12.74
Fibonacci 38.2% 11.24
Last Price 8.77
52-Week Low 6.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective